High Complexity Assisted Reproduction Treatments In The Reproductive Medicine Service At The Maternal Perinatal National Institute Experience August-November 2014
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Objectives. To describe and evaluate the outcome of highly complex assisted reproduction treatments in the Reproductive Medicine
Service of the INMP in the period August-November 2014. Material and methods. Descriptive, observational and retrospective
study. We included all patients with indications of highly complex assisted reproduction treatments who received at least one In
Vitro Fertilization cycle during August-November 2014. Each patient received a cycle of ovarian stimulation with recombinant
follicle stimulating hormone (FSH-r) and / Or Highly Purified Human Menopause Hormone (HMG-HP), Cetrorelix and Chorionic
Gonadotropin (HCG) Hormone. All patients received a regimen of controlled ovarian stimulation, follicular aspiration, In Vitro
Fertilization and Embryo Transfer in the Reproductive Medicine Service and Laboratory of Gametes and Embryos of the INMP. Day
3 embryos (stage D + 3) were transferred. Clinical records were reviewed with a collection record and the data obtained were sorted
and processed in a database using the SPSS Version 19 statistical package.